August 2015, Vol 3, No 8
In a recent conversation with a reader, the challenges of discussing over-the-counter medication use with patients were explored. How do you have that conversation if you don’t know they are in your store at this very moment, picking up a decongestant or a supplement?
As pharmacists involved in daily work activities, it is often difficult to recognize or identify changes in our pharmacy or profession. I recently reviewed the 2014 National Pharmacist Workforce Survey, which has surveyed pharmacists since 2000. The most recent report, released in April 2015, provides data from 2014, and is an update to the 2009 survey. The report contains a wealth of information about the pharmacy profession, and I was most intrigued by the changing dynamics in pharmacy leading to the provision of more clinical services.
- Patients Should Be Cautioned About Symptom Checkers
- Patients with Diabetes Nonadherent to Immunization Guidelines
- Antibiotics Linked to Juvenile Idiopathic Arthritis
- Vitamin C May Reduce Risk For Heart Disease, All-Cause Mortality
- Breast Cancer Screening
It is never too early to start preparing for the flu season. With last season’s drifted influenza A (H3N2) viruses, and >200,000 reported influenza-associated hospitalizations every year, it is imperative that we start planning for the upcoming flu season.
In a recent interview with Inside Patient Care, Gary Wiltz, MD, Executive Director/Clinical Director, Teche Action Board, Inc, Franklin, LA, discussed the National Association of Community Health Centers and Teche Action Clinic, as well as improving patient care using a multifaceted approach to care.
Shirin Madzhidova, PharmD, Sheava K Blackman, PharmDc, Ryan D Dunn, PharmDc, Arghavan Kariman, PharmDc, Danielle Lerch, PharmDc, Joseph J Sodoro, PharmDc
According to the American Psychiatric Association, autism spectrum disorder (ASD) is classified as a persistent abnormal neurodevelopmental disorder appearing in early childhood and characterized by deficits in social, emotional, behavioral, verbal, and cognitive functioning.
Lemtrada (Alemtuzumab) a New Treatment Option Approved by the FDA for the Treatment of Relapsing Forms of Multiple Sclerosis
Multiple sclerosis (MS), a chronic, inflammatory disease of the central nervous system, disrupts the communication between the brain, spinal cord, and other areas of the body. Aside from being potentially debilitating, MS can result in irreversible nerve deterioration. The incidence and prevalence of MS are not consistently tracked in the United States; it is estimated that 400,000 Americans are currently affected by the disease.
Results 1 - 10 of 10